🔥 We have been featured on Shark Tank India.Episode 13

🔥 We have been featured on Shark Tank India

logologo
Search anything
Ctrl+K
gift
arrow
WhatsApp Icon

Stock Summary and Key Metrics













Investment Checklist




























Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Ask AI

mockupmockup

Standalone Quarterly Results (in ₹ Crores)

Total Figures
QoQ Changes
Total Figures
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales0.328.83150.340.39265.400.680.689.78
Expenses0.188.33280.260.34244.890.290.247.63
Operating Profit0.140.50-140.080.052.350.510.390.442.15
OPM %43.755.66-91.2523.5312.828.939.4457.3564.7121.98
Other Income0.000.000.000.000.000.000.000.000.000.00
Interest0.000.000.040.000.000.000.000.000.000.00
Depreciation0.010.010.010.010.010.010.010.010.010.01
Profit Before Tax0.130.50-140.070.042.350.500.380.432.14
Tax %23.0824.001.400.000.000.000.000.000.000.00
Net Profit0.090.37-130.070.042.350.500.380.432.14
EPS in Rs0.020.07-2.680.010.010.320.100.080.090.43

Standalone Profit Loss (in ₹ Crores)

Total Figures
YoY Changes
Total Figures
Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales395.51177.352.210.684.63243233
Expenses364.41156.901.940.864.15372930
Operating Profit2.681.101.400.450.28-0.180.48-132.983.30
OPM %6.8619.948.416.1612.44-26.2110.32-52.519.2010.06
Other Income0.830.060.410.030.000.020.000.000.00NaN
Interest0.190.010.070.150.010.000.000.040.000.00
Depreciation0.010.010.010.020.040.040.040.040.040.04
Profit Before Tax3.311.141.740.310.23-0.200.44-132.953.27
Tax %27.2626.9528.9323.4125.54-19.9947.370.03-0.160.00
Net Profit2.410.831.230.240.17-0.240.23-132.953.27
EPS in Rs0.490.170.250.050.04-0.050.05-2.570.440.70
Dividend Payout %0.000.000.000.000.000.000.000.000.00

Standalone Balance Sheet (in ₹ Crores)

Total Figures
YoY Changes
Total Figures
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital30303030303030303044
Reserves8.34111213131313130.384.89
Borrowings0.000.000.000.000.000.000.000.000.000.00
Other Liabilities1.021.490.390.710.830.690.140.240.140.13
Total Liabilities39424243434443433149
Fixed Assets0.450.450.440.430.620.590.560.530.490.45
CWIP0.000.000.000.000.000.000.000.000.000.00
Investments2.161.494.1018171816167.037.03
Other Assets37403825252527272341
Total Assets39424243434443433149

Standalone Cash Flows (in ₹ Crores)

Total Figures
YoY Changes
Total Figures
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity-6.28-1.822.85121.950.18-2.19-0.07-0.20-15
Cash from Investing Activity-2.141.19-2.39-14-0.22-0.002.40-0.000.00-0.00
Cash from Financing Activity0.000.000.000.000.000.000.000.000.0015
Net Cash Flow-8.41-0.630.46-2.461.730.180.21-0.07-0.200.04

Documents

Presentations
Concalls
Reports
Presentations

No documents found!

Actions

Action Type




























































AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Ask AI

ai-corner-premiumai-corner-premium
ai-corner-premiumai-corner-premium

Frequently Asked Questions about Fervent Synergies Ltd

Fervent Synergies Ltd (FERVENTSYN) is currently trading at 17.30 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Fervent Synergies Ltd is engaged in the trading and distribution of pharmaceutical and chemical products, focusing on APIs, solvents, intermediates, and bulk drugs. Originally incorporated as Fervent Pharma Synergies Ltd in 2009, the company underwent a name change in 2012 after mergers with Midas Pharmasec Ltd and Yew Investment Pvt Ltd. The company expanded its scope by merging with Midas Pharmasec Ltd, enhancing its pharmaceutical business operations and gaining synergies. Fervent Synergies Ltd's shares are publicly traded on the Bombay Stock Exchange since January 12, 2012, providing investor access and funding opportunities. Their primary business operations include import-export activities, leveraging global connections to distribute a wide array of chemical products.

Over the past 52 weeks, Fervent Synergies Ltd has traded between a low of ₹16.20 and a high of ₹29.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Fervent Synergies Ltd has a market capitalization of approximately 86.90. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Fervent Synergies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 24.85 and operates in the Trading sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 86.90 Cr, Fervent Synergies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Fervent Synergies Ltd operates in the Trading sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Fervent Synergies Ltd is 24.85. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.